Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation

The Lancet Infectious Diseases

Volumn 17, Issue 3, 2017, Pages 275-284

  Yang, Chongguang ^a,e   Luo, Tao ^a,c   Shen, Xin ^b   Wu, Jie ^b   Gan, Mingyu ^a   Xu, Peng ^a   Wu, Zheyuan ^b   Lin, Senlin ^b   Tian, Jiyun ^a   Liu, Qingyun ^a   Yuan, ZhengAn ^b   Mei, Jian ^b   DeRiemer, Kathryn ^d   Gao, Qian ^a  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Municipal Centre for Disease Control and Prevention   (China)

^c SICHUAN UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; CHINA; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEALTH PROGRAM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PHYLOGENY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM CULTURE; SPUTUM SMEAR; TUBERCULOSIS CONTROL; VARIABLE NUMBER OF TANDEM REPEAT; WHOLE GENOME SEQUENCING; BACTERIAL GENOME; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOME, BACTERIAL; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 85007504805     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30418-2     Document Type: Article

References (31)

1. 1 WHO. Global tuberculosis report 2016. http://www.who.int/tb/publications/global_report/en/ (accessed Oct 13, 2016).
2. 2 Nathanson, E, Nunn, P, Uplekar, M, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med 363 (2010), 1050–1058.
3. 3 Barnes, PF, Cave, MD, Molecular epidemiology of tuberculosis. N Engl J Med 349 (2003), 1149–1156.
4. 4 Gardy, JL, Johnston, JC, Ho Sui, SJ, et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364 (2011), 730–739.
5. 5 Casali, N, Nikolayevskyy, V, Balabanova, Y, et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 46 (2014), 279–286.
6. 6 Cohen, KA, Abeel, T, Manson McGuire, A, et al. Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal. PLoS Med, 12, 2015, e1001880.
7. 7 Luo, T, Yang, C, Peng, Y, et al. Whole-genome sequencing to detect recent transmission of Mycobacterium tuberculosis in settings with a high burden of tuberculosis. Tuberculosis (Edinb) 94 (2014), 434–440.
8. 8 Walker, TM, Ip, CLC, Harrell, RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13 (2013), 137–146.
9. 9 Walker, TM, Lalor, MK, Broda, A, et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study. Lancet Respir Med 2 (2014), 285–292.
10. 10 Casali, N, Broda, A, Harris, SR, Parkill, J, Drobniewski, F, Whole genome sequence analysis of a large isoniazid-resistant tuberculosis outbreak in London: a retrospective observational study. PLoS Med, 13, 2016, e1002137.
11. 11 Anderson, LF, Tamne, S, Brown, T, et al. Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing. Lancet Infect Dis 14 (2014), 406–415.
12. 12 Dobler, CC, Korver, S, Batbayar, O, et al. Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010-2011. Emerg Infect Dis 21 (2015), 1451–1454.
13. 13 Moonan, PK, Teeter, LD, Salcedo, K, et al. Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study. Lancet Infect Dis 13 (2013), 777–784.
14. 14 Kendall, EA, Fofana, MO, Dowdy, DW, Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med 3 (2015), 963–972.
15. 15 Flandrois, JP, Lina, G, Dumitrescu, O, MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis. BMC Bioinformatics, 15, 2014, 107.
16. 16 Yang, C, Shen, X, Peng, Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis 61 (2015), 219–227.
17. 17 Luo, T, Comas, I, Luo, D, et al. Southern East Asian origin and coexpansion of Mycobacterium tuberculosis Beijing family with Han Chinese. Proc Natl Acad Sci USA 112 (2015), 8136–8141.
18. 18 Luo, T, Yang, C, Pang, Y, Zhao, Y, Mei, J, Gao, Q, Development of a hierarchical variable-number tandem repeat typing scheme for Mycobacterium tuberculosis in China. PLoS One, 9, 2014, e89726.
19. 19 Li, H, Handsaker, B, Wysoker, A, et al. The sequence alignment/map format and SAMtools. Bioinformatics 25 (2009), 2078–2079.
20. 20 Sun, G, Luo, T, Yang, C, et al. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis 206 (2012), 1724–1733.
21. 21 Comas, I, Borrell, S, Roetzer, A, et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 44 (2012), 106–110.
22. 22 Li, X, Zhang, Y, Shen, X, et al. Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis 195 (2007), 864–869.
23. 23 Zhao, Y, Xu, S, Wang, L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 366 (2012), 2161–2170.
24. 24 Bryant, JM, Harris, SR, Parkhill, J, et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med 1 (2013), 786–792.
25. 25 Guerra-Assuncao, JA, Crampin, AC, Houben, RM, et al. Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area. Elife, 4, 2015, e05166.
26. 26 Kato-Maeda, M, Ho, C, Passarelli, B, et al. Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak. PLoS One, 8, 2013, e58235.
27. 27 Perez-Lago, L, Comas, I, Navarro, Y, et al. Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J Infect Dis 209 (2014), 98–108.
28. 28 Xue He, G, van den Hof, S, van der Werf, MJ, et al. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. Clin Infect Dis 52 (2011), e153–e156.
29. 29 Cohen, T, Murray, M, Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 10 (2004), 1117–1121.
30. 30 Gagneux, S, Long, CD, Small, PM, Van, T, Schoolnik, GK, Bohannan, BJ, The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312 (2006), 1944–1946.
31. 31 de Vos, M, Muller, B, Borrell, S, et al. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Agents Chemother 57 (2013), 827–832.